Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 28
Filtrer
1.
Nucleic Acids Res ; 52(2): 708-723, 2024 Jan 25.
Article de Anglais | MEDLINE | ID: mdl-38000366

RÉSUMÉ

Replication of Vibrio cholerae chromosome 2 (Chr2) initiates when the Chr1 locus, crtS (Chr2 replication triggering site) duplicates. The site binds the Chr2 initiator, RctB, and the binding increases when crtS is complexed with the transcription factor, Lrp. How Lrp increases the RctB binding and how RctB is subsequently activated for initiation by the crtS-Lrp complex remain unclear. Here we show that Lrp bends crtS DNA and possibly contacts RctB, acts that commonly promote DNA-protein interactions. To understand how the crtS-Lrp complex enhances replication, we isolated Tn-insertion and point mutants of RctB, selecting for retention of initiator activity without crtS. Nearly all mutants (42/44) still responded to crtS for enhancing replication, exclusively in an Lrp-dependent manner. The results suggest that the Lrp-crtS controls either an essential function or more than one function of RctB. Indeed, crtS modulates two kinds of RctB binding to the origin of Chr2, ori2, both of which we find to be Lrp-dependent. Some point mutants of RctB that are optimally modulated for ori2 binding without crtS still remained responsive to crtS and Lrp for replication enhancement. We infer that crtS-Lrp functions as a unit, which has an overarching role, beyond controlling initiator binding to ori2.


Sujet(s)
Protéines bactériennes , Réplication de l'ADN , Protéine régulatrice à leucines , Vibrio cholerae , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , ADN/métabolisme , Régulation de l'expression des gènes bactériens , Facteurs de transcription/génétique , Facteurs de transcription/métabolisme , Vibrio cholerae/génétique , Vibrio cholerae/métabolisme , Protéine régulatrice à leucines/métabolisme
2.
JNMA J Nepal Med Assoc ; 60(248): 364-368, 2022 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-35633222

RÉSUMÉ

Introduction: Preterm babies are born before 37 completed weeks of gestation. It is an important cause of neonatal morbidity and mortality. This study aimed to find out the prevalence of neonatal intensive care unit admissions among preterm babies in a tertiary care centre. Methods: A descriptive cross-sectional study on a total of 133 preterm infants was conducted in a tertiary care centre from November, 2020 to April, 2021 with ethical approval from the Institutional Review Committee (Reference number: 380). Preterm babies who met the eligibility criteria were included in the study. Convenience sampling was done. Data were analysed using the Statistical Package for the Social Sciences version 20.0. Point estimate at 95% Confidence Interval was calculated along with frequency and percentage for binary data. Results: Out of 133 preterm babies, 54 (40.60%) (32.25-48.95 at 95% Confidence Interval) had neonatal intensive care unit admissions. Hyaline membrane disease was the most common illness in preterm neonates 34 (62.96%) followed by neonatal sepsis 20 (37.03%). Conclusions: The prevalence of neonatal intensive care unit admissions among preterm babies in our study was similar to other studies done in similar settings. Preterm newborns are significantly vulnerable and maternal risk factors should be taken into account. Anticipated preterm deliveries should have mandatory institutional delivery and adequate postnatal care is needed to improve the outcomes of preterm babies. Keywords: morbidity; mortality; neonatal intensive care unit; preterm infants.


Sujet(s)
Maladies néonatales , Unités de soins intensifs néonatals , Études transversales , Humains , Nourrisson , Nouveau-né , Prématuré , Centres de soins tertiaires
3.
Biomedicines ; 9(9)2021 Aug 29.
Article de Anglais | MEDLINE | ID: mdl-34572293

RÉSUMÉ

Inflammatory bowel disease (IBD) is characterized by gastrointestinal inflammation comprised of Crohn's disease and ulcerative colitis. Centers for Disease Control and Prevention report that 1.3% of the population of the United States (approximately 3 million people) were affected by the disease in 2015, and the number keeps increasing over time. IBD has a multifactorial etiology, from genetic to environmental factors. Most of the IBD treatments revolve around disease management, by reducing the inflammatory signals. We previously identified the surface layer protein A (SlpA) of Lactobacillus acidophilus that possesses anti-inflammatory properties to mitigate murine colitis. Herein, we expressed SlpA in a clinically relevant, food-grade Lactococcus lactis to further investigate and characterize the protective mechanisms of the actions of SlpA. Oral administration of SlpA-expressing L. lactis (R110) mitigated the symptoms of murine colitis. Oral delivery of R110 resulted in a higher expression of IL-27 by myeloid cells, with a synchronous increase in IL-10 and cMAF in T cells. Consistent with murine studies, human dendritic cells exposed to R110 showed exquisite differential gene regulation, including IL-27 transcription, suggesting a shared mechanism between the two species, hence positioning R110 as potentially effective at treating colitis in humans.

4.
Science ; 373(6558): 1040-1046, 2021 08 27.
Article de Anglais | MEDLINE | ID: mdl-34446607

RÉSUMÉ

The antitumor efficacy of cancer immunotherapy can correlate with the presence of certain bacterial species within the gut microbiome. However, many of the molecular mechanisms that influence host response to immunotherapy remain elusive. In this study, we show that members of the bacterial genus Enterococcus improve checkpoint inhibitor immunotherapy in mouse tumor models. Active enterococci express and secrete orthologs of the NlpC/p60 peptidoglycan hydrolase SagA that generate immune-active muropeptides. Expression of SagA in nonprotective E. faecalis was sufficient to promote immunotherapy response, and its activity required the peptidoglycan sensor NOD2. Notably, SagA-engineered probiotics or synthetic muropeptides also augmented anti-PD-L1 antitumor efficacy. Taken together, our data suggest that microbiota species with specialized peptidoglycan remodeling activity and muropeptide-based therapeutics may enhance cancer immunotherapy and could be leveraged as next-generation adjuvants.


Sujet(s)
Antigène CD274/antagonistes et inhibiteurs , Enterococcus/métabolisme , Inhibiteurs de points de contrôle immunitaires/usage thérapeutique , Mélanome expérimental/thérapie , N-acetylmuramoyl-l-alanine amidase/métabolisme , Peptidoglycane/métabolisme , Animaux , Charge bactérienne , Protéines bactériennes/métabolisme , Enterococcus/enzymologie , Enterococcus faecalis/métabolisme , Enterococcus faecium/métabolisme , Microbiome gastro-intestinal , Immunothérapie , Mélanome expérimental/immunologie , Souris , Souris de lignée C57BL , Protéine adaptatrice de signalisation NOD2/métabolisme , Fragments peptidiques/métabolisme , Probiotiques , Transduction du signal
5.
J Nepal Health Res Counc ; 19(1): 62-65, 2021 Apr 23.
Article de Anglais | MEDLINE | ID: mdl-33934134

RÉSUMÉ

BACKGROUND: The study is aimed at highlighting the pattern of congenital defect in a tertiary care hospital. Congenital anomalies are recognized as a growing cause of neonatal morbidity and mortality in developing countries and a major cause of distress to parents. METHODS: This was a prospective descriptive study conducted between September 2019 and August 2020 with the objective to determine the types of congenital anomalies among live born neonates at Manipal Teaching Hospital (MTH), Pokhara and to determine their immediate outcome. Neonatal and maternal characteristics were noted. RESULTS: Twenty four out of 2515 live births had congenital anomalies during the study period, giving an incidence rate of 9.42 congenital anomalies per 1000 live birth per year. Single system involvement was seen in 79.2 % cases, remaining 5 (20.8%) neonates had involvement of more than one system; 54.2% of these newborns were discharged, 33.3% expired, 8.3% left against medical advice and 4.2% were referred out. CONCLUSIONS: This study highlights the importance of clinical examination of neonates to detect anomalies in our setting.


Sujet(s)
Malformations , Malformations/épidémiologie , Humains , Incidence , Nouveau-né , Népal/épidémiologie , Études prospectives
6.
Nucleic Acids Res ; 48(19): 11016-11029, 2020 11 04.
Article de Anglais | MEDLINE | ID: mdl-33035310

RÉSUMÉ

Studies of bacterial chromosomes and plasmids indicate that their replication initiator proteins bind to origins of replication at many double-stranded sites and also at AT-rich regions where single-stranded DNA is exposed during origin opening. Single-strand binding apparently promotes origin opening by stabilizing an open structure, but how the initiator participates in this process and the contributions of the several binding sites remain unclear. Here, we show that the initiator protein of Vibrio cholerae specific to chromosome 2 (Chr2) also has single-strand binding activity in the AT-rich region of its origin. Binding is strand specific, depends on repeats of the sequence 5'ATCA and is greatly stabilized in vitro by specific double-stranded sites of the origin. The stability derives from the formation of ternary complexes of the initiator with the single- and double-stranded sites. An IHF site lies between these two kinds of sites in the Chr2 origin and an IHF-induced looping out of the intervening DNA mediates their interaction. Simultaneous binding to two kinds of sites in the origin appears to be a common mechanism by which bacterial replication initiators stabilize an open origin.


Sujet(s)
Protéines bactériennes/métabolisme , Chromosomes de bactérie/métabolisme , Helicase/métabolisme , Réplication de l'ADN , ADN bactérien/métabolisme , Protéines de liaison à l'ADN/métabolisme , Transactivateurs/métabolisme , Vibrio cholerae/génétique , Sites de fixation , Régulation de l'expression des gènes bactériens , Liaison aux protéines , Origine de réplication
7.
BMC Neurol ; 20(1): 286, 2020 Jul 27.
Article de Anglais | MEDLINE | ID: mdl-32718330

RÉSUMÉ

BACKGROUND: Central sensitization is thought to be an important contributing factor in many chronic pain disorders. The Central Sensitization Inventory (CSI) is a patient-reported measure frequently used to assess symptoms related to central sensitization. The aims of the study were to translate and cross-culturally adapt the CSI into Nepali (CSI-NP) and assess its measurement properties. METHODS: The CSI was translated into Nepali using recommended guidelines. The CSI-NP was then administered on 100 Nepalese adults with sub-acute and chronic musculoskeletal pain with additional demographic and pain-related questions. The CSI-Nepali was administered again about 2 weeks later. Four measurement properties of the CSI-NP were evaluated: (1) internal consistency using Cronbach's alpha, (2) test-retest reliability using intraclass correlation coefficient (ICC2,1), (3) measurement errors, and (4) construct validity testing five a priori hypotheses. Confirmation of construct validity was determined if a minimum of 75% of the hypotheses were met. RESULTS: The CSI was successfully translated into Nepali. Internal consistency and test-retest reliability were both excellent (Cronbach's alpha = 0.91, and ICC = 0.98). The standard error of measurement was 0.31 and the smallest detectable change was 0.86. Four out of five (80%) a priori hypotheses were met, confirming the construct validity: the CSI-NP correlated strongly with the Pain Catastrophizing Scale total scores (r = 0.50); moderately with the total number of pain descriptors (r = 0.35); weakly with the Numerical Rating Scale (r = 0.25); and women had significantly higher CSI scores than men. However, the CSI scores did not correlate significantly with the total duration of pain, as hypothesized (r = 0.10). CONCLUSIONS: The Nepali translation of the CSI demonstrated excellent reliability and construct validity in adults with musculoskeletal pain. It is now available to Nepali health care providers to help assess central sensitization-related signs and symptoms in individuals with musculoskeletal pain in research or clinical practice to advance the understanding of central sensitization in Nepalese samples.


Sujet(s)
Catastrophisation/physiopathologie , Sensibilisation du système nerveux central/physiologie , Comparaison interculturelle , Douleur musculosquelettique/physiopathologie , Psychométrie , Traductions , Adulte , Catastrophisation/complications , Femelle , Humains , Études longitudinales , Mâle , Douleur musculosquelettique/complications , Népal , Mesure de la douleur/méthodes , Reproductibilité des résultats , Autorapport
8.
Health Phys ; 119(6): 746-757, 2020 12.
Article de Anglais | MEDLINE | ID: mdl-32384373

RÉSUMÉ

The molecule 3,3'-diindolylmethane (DIM) is small, a major bioactive metabolite of indole-3 carbinol (13C), and a phytochemical compound from cruciferous vegetables released upon exposure to the gut acid environment. DIM is a proposed anti-cancer agent and was previously demonstrated to prevent radiation damage in the bone marrow and the gastrointestinal tract. Here we investigated the effect of DIM on radiation-induced injury to the lung in a murine model through untargeted metabolomics and gene expression studies of select genes. CBA mice were exposed to thoracic irradiation (17.5 Gy). Mice were treated with vehicle or DIM (250 mg kg, subcutaneous injection) on days -1 pre-irradiation through +14 post-irradiation. DIM induced a significant improvement in survival by day 150 post-irradiation. Fibrosis-related gene expression and metabolomics were examined using lung tissue from days 15, 45, 60, 90, and 120 post-irradiation. Our qRT-PCR experiments showed that DIM treatment reduced radiation-induced late expression of collagen Iα and the cell cycle checkpoint proteins p21/waf1 (CDKN1A) and p16ink (CDKN2A). Metabolomic studies of lung tissue demonstrated a significant dampening of radiation-induced changes following DIM treatment. Metabolites associated with pro-inflammatory responses and increased oxidative stress, such as fatty acids, were suppressed by DIM treatment compared to irradiated samples. Together these data suggest that DIM reduces radiation-induced sequelae in the lung.


Sujet(s)
Anticarcinogènes/pharmacologie , Indoles/pharmacologie , Lésion pulmonaire/traitement médicamenteux , Lésions radiques expérimentales/traitement médicamenteux , Thorax/effets des radiations , Rayons X/effets indésirables , Animaux , Femelle , Lésion pulmonaire/étiologie , Lésion pulmonaire/anatomopathologie , Souris , Souris de lignée CBA , Lésions radiques expérimentales/étiologie , Lésions radiques expérimentales/anatomopathologie
9.
Nucleic Acids Res ; 48(1): 200-211, 2020 01 10.
Article de Anglais | MEDLINE | ID: mdl-31665475

RÉSUMÉ

Escherichia coli replication initiator protein DnaA binds ATP with high affinity but the amount of ATP required to initiate replication greatly exceeds the amount required for binding. Previously, we showed that ATP-DnaA, not ADP-DnaA, undergoes a conformational change at the higher nucleotide concentration, which allows DnaA oligomerization at the replication origin but the association state remains unclear. Here, we used Small Angle X-ray Scattering (SAXS) to investigate oligomerization of DnaA in solution. Whereas ADP-DnaA was predominantly monomeric, AMP-PNP-DnaA (a non-hydrolysable ATP-analog bound-DnaA) was oligomeric, primarily dimeric. Functional studies using DnaA mutants revealed that DnaA(H136Q) is defective in initiating replication in vivo. The mutant retains high-affinity ATP binding, but was defective in producing replication-competent initiation complexes. Docking of ATP on a structure of E. coli DnaA, modeled upon the crystallographic structure of Aquifex aeolicus DnaA, predicts a hydrogen bond between ATP and imidazole ring of His136, which is disrupted when Gln is present at position 136. SAXS performed on AMP-PNP-DnaA (H136Q) indicates that the protein has lost its ability to form oligomers. These results show the importance of high ATP in DnaA oligomerization and its dependence on the His136 residue.


Sujet(s)
ADP/composition chimique , Adénosine triphosphate/composition chimique , Protéines bactériennes/composition chimique , Réplication de l'ADN , ADN bactérien/génétique , Protéines de liaison à l'ADN/composition chimique , Escherichia coli/génétique , Régulation de l'expression des gènes bactériens , ADP/métabolisme , Adénosine triphosphate/métabolisme , Adenylyl imidodiphosphate/composition chimique , Adenylyl imidodiphosphate/métabolisme , Aquifex , Bactéries/génétique , Bactéries/métabolisme , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Sites de fixation , Chromosomes de bactérie/composition chimique , Chromosomes de bactérie/métabolisme , Cristallographie aux rayons X , ADN bactérien/métabolisme , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Dimérisation , Escherichia coli/métabolisme , Liaison hydrogène , Simulation de docking moléculaire , Mutation , Plasmides/composition chimique , Plasmides/métabolisme , Liaison aux protéines , Structure en hélice alpha , Motifs et domaines d'intéraction protéique , Protéines recombinantes/composition chimique , Protéines recombinantes/génétique , Protéines recombinantes/métabolisme , Origine de réplication , Thermodynamique
10.
Sci Rep ; 9(1): 2198, 2019 02 18.
Article de Anglais | MEDLINE | ID: mdl-30778109

RÉSUMÉ

The increasing potential for accidental radiation exposure from either nuclear accidents or terrorist activities has escalated the need for radiation countermeasure development. We previously showed that a 30-day course of high-dose captopril, an ACE inhibitor, initiated 1-4 h after total body irradiation (TBI), improved Hematopoietic Acute Radiation Syndrome (H-ARS) and increased survival in mice. However, because of the time likely required for the deployment of a stockpiled radiation countermeasure to a radiation mass casualty site, there is a need for therapies that can be administered 24-48 hours after initial exposure. Using C57BL/6 mice exposed to an LD50-80/30 of 60Co TBI (7.75-7.9 Gy, 0.615 Gy/min), we show that low-dose captopril administration, initiated as late as 48 h post-TBI and continued for 14 days, significantly enhanced overall survival similarly to high-dose, rapid administration. Captopril treatment did not affect radiation-induced cell cycle arrest genes or the immediate loss of hematopoietic precursors. Reduced mortality was associated with the recovery of bone marrow cellularity and mature blood cell recovery at 21-30 days post-irradiation. Captopril reduced radiation-induced cytokines EPO, G-CSF, and SAA in the plasma. Finally, delayed captopril administration mitigated brain micro-hemorrhage at 21 days post-irradiation. These data indicate that low dose captopril administered as late as 48 h post-TBI for only two weeks improves survival that is associated with hematopoietic recovery and reduced inflammatory response. These data suggest that captopril may be an ideal countermeasure to mitigate H-ARS following accidental radiation exposure.


Sujet(s)
Inhibiteurs de l'enzyme de conversion de l'angiotensine/administration et posologie , Captopril/administration et posologie , Hématopoïèse/effets des médicaments et des substances chimiques , Hématopoïèse/effets des radiations , Radioprotecteurs/administration et posologie , Irradiation corporelle totale , Syndrome d'irradiation aigu/sang , Syndrome d'irradiation aigu/étiologie , Syndrome d'irradiation aigu/mortalité , Syndrome d'irradiation aigu/prévention et contrôle , Animaux , Hémogramme , Cycle cellulaire/effets des médicaments et des substances chimiques , Cycle cellulaire/effets des radiations , Cytokines/métabolisme , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Relation dose-effet des rayonnements , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/effets des radiations , Cellules souches hématopoïétiques/effets des médicaments et des substances chimiques , Cellules souches hématopoïétiques/métabolisme , Cellules souches hématopoïétiques/effets des radiations , Médiateurs de l'inflammation/métabolisme , Souris , Dose de rayonnement , Exposition aux rayonnements , Délai jusqu'au traitement , Irradiation corporelle totale/effets indésirables
11.
J Pain Res ; 11: 2385-2396, 2018.
Article de Anglais | MEDLINE | ID: mdl-30425551

RÉSUMÉ

BACKGROUND: Both socioeconomic and psychological factors have been shown to predict patient function in samples of individuals with chronic pain in Western countries. However, little is known about their role as predictors of function in individuals with chronic pain from developing countries. PURPOSE: The purpose of this study was to examine the associations between measures of socioeconomic factors (income, education) and psychological factors (catastrophizing and resilience) and measures of function in a sample of individuals with chronic pain from rural Nepal. In addition, we sought to evaluate the moderating effects of socioeconomic factors on the associations between the psychological variables and function. METHODS: We interviewed 143 adults with chronic musculoskeletal pain from rural areas of Nepal to assess income, education level, pain intensity, catastrophizing, resilience, physical function, and depression. We performed two regression analyses to evaluate the direct and unique effects of the socioeconomic and psychological variables and pain intensity as predictors of patient function, as well as the moderating influence of income, education level, and pain intensity on the associations between the psychological variables and function. RESULTS: Education and income both predicted physical function, but only income predicted depression. In addition, pain catastrophizing, but not resilience, evidenced a direct and significant independent association with depression. Neither catastrophizing nor resilience made independent and significant direct contributions to the prediction of physical function. The association between resilience and physical function was moderated by pain intensity and income, and income (but not education or pain intensity) moderated the associations between both 1) resilience and depression and 2) catastrophizing and depression. CONCLUSION: The results suggest the possibility that cultural differences may influence the role that psychosocial factors play in chronic pain adjustment. These findings have important implications regarding how psychosocial pain interventions should be adapted by individuals in developing countries.

12.
Elife ; 72018 10 02.
Article de Anglais | MEDLINE | ID: mdl-30277210

RÉSUMÉ

Binary fission has been well studied in rod-shaped bacteria, but the mechanisms underlying cell division in spherical bacteria are poorly understood. Rod-shaped bacteria harbor regulatory proteins that place and remodel the division machinery during cytokinesis. In the spherical human pathogen Staphylococcus aureus, we found that the essential protein GpsB localizes to mid-cell during cell division and co-constricts with the division machinery. Depletion of GpsB arrested cell division and led to cell lysis, whereas overproduction of GpsB inhibited cell division and led to the formation of enlarged cells. We report that S. aureus GpsB, unlike other Firmicutes GpsB orthologs, directly interacts with the core divisome component FtsZ. GpsB bundles and organizes FtsZ filaments and also stimulates the GTPase activity of FtsZ. We propose that GpsB orchestrates the initial stabilization of the Z-ring at the onset of cell division and participates in the subsequent remodeling of the divisome during cytokinesis.


Sujet(s)
Protéines bactériennes/métabolisme , Protéines du cytosquelette/métabolisme , Staphylococcus aureus/métabolisme , Facteurs de virulence/métabolisme , Protéines bactériennes/génétique , Division cellulaire/génétique , Protéines du cytosquelette/génétique , dGTPases/génétique , dGTPases/métabolisme , Gènes essentiels/génétique , Protéines à fluorescence verte/génétique , Protéines à fluorescence verte/métabolisme , Guanosine triphosphate/métabolisme , Humains , Hydrolyse , Microscopie de fluorescence , Liaison aux protéines , Infections à staphylocoques/microbiologie , Staphylococcus aureus/génétique , Imagerie accélérée/méthodes , Facteurs de virulence/génétique
13.
J Cell Mol Med ; 22(9): 4274-4282, 2018 09.
Article de Anglais | MEDLINE | ID: mdl-29971909

RÉSUMÉ

Allogeneic stem cell transplantation is currently the only curative therapy for primary myelofibrosis (MF), while the JAK2 inhibitor, ruxolitinib. Has been approved only for palliation. Other therapies are desperately needed to reverse life-threatening MF. However, the cell(s) and cytokine(s) that promote MF remain unclear. Several reports have demonstrated that captopril, an inhibitor of angiotensin-converting enzyme that blocks the production of angiotensin II (Ang II), mitigates fibrosis in heart, lung, skin and kidney. Here, we show that captopril can mitigate the development of MF in the Gata1low mouse model of primary MF. Gata1low mice were treated with 79 mg/kg/d captopril in the drinking water from 10 to 12 months of age. At 13 months of age, bone marrows were examined for fibrosis, megakaryocytosis and collagen expression; spleens were examined for megakaryocytosis, splenomegaly and collagen expression. Treatment of Gata1low mice with captopril in the drinking water was associated with normalization of the bone marrow cellularity; reduced reticulin fibres, splenomegaly and megakaryocytosis; and decreased collagen expression. Our findings suggest that treating with the ACE inhibitors captopril has a significant benefit in overcoming pathological changes associated with MF.


Sujet(s)
Inhibiteurs de l'enzyme de conversion de l'angiotensine/pharmacologie , Antinéoplasiques/pharmacologie , Captopril/pharmacologie , Facteur de transcription GATA-1/génétique , Myélofibrose primitive/traitement médicamenteux , Splénomégalie/traitement médicamenteux , Administration par voie orale , Animaux , Moelle osseuse/effets des médicaments et des substances chimiques , Moelle osseuse/métabolisme , Moelle osseuse/anatomopathologie , Collagène/antagonistes et inhibiteurs , Collagène/génétique , Collagène/métabolisme , Modèles animaux de maladie humaine , Eau de boisson/administration et posologie , Repositionnement des médicaments , Femelle , Facteur de transcription GATA-1/déficit , Expression des gènes , Mâle , Mégacaryocytes/effets des médicaments et des substances chimiques , Mégacaryocytes/métabolisme , Mégacaryocytes/anatomopathologie , Souris , Souris knockout , Myélofibrose primitive/génétique , Myélofibrose primitive/métabolisme , Myélofibrose primitive/anatomopathologie , Réticuline/antagonistes et inhibiteurs , Réticuline/génétique , Réticuline/métabolisme , Splénomégalie/génétique , Splénomégalie/métabolisme , Splénomégalie/anatomopathologie
14.
PLoS Genet ; 14(5): e1007426, 2018 05.
Article de Anglais | MEDLINE | ID: mdl-29795553

RÉSUMÉ

Initiation of chromosome replication in bacteria is precisely timed in the cell cycle. Bacteria that harbor multiple chromosomes face the additional challenge of orchestrating replication initiation of different chromosomes. In Vibrio cholerae, the smaller of its two chromosomes, Chr2, initiates replication after Chr1 such that both chromosomes terminate replication synchronously. The delay is due to the dependence of Chr2 initiation on the replication of a site, crtS, on Chr1. The mechanism by which replication of crtS allows Chr2 replication remains unclear. Here, we show that blocking Chr1 replication indeed blocks Chr2 replication, but providing an extra crtS copy in replication-blocked Chr1 permitted Chr2 replication. This demonstrates that unreplicated crtS copies have significant activity, and suggests that a role of replication is to double the copy number of the site that sufficiently increases its activity for licensing Chr2 replication. We further show that crtS activity promotes the Chr2-specific initiator function and that this activity is required in every cell cycle, as would be expected of a cell-cycle regulator. This study reveals how increase of gene dosage through replication can be utilized in a critical regulatory switch.


Sujet(s)
Protéines bactériennes/génétique , Chromosomes de bactérie/génétique , ADN bactérien/génétique , Dosage génique , Vibrio cholerae/génétique , Division cellulaire/génétique , Réplication de l'ADN/génétique , Régulation de l'expression des gènes bactériens , Origine de réplication
15.
mBio ; 8(2)2017 04 18.
Article de Anglais | MEDLINE | ID: mdl-28420739

RÉSUMÉ

Replication of Vibrio cholerae chromosome 2 (Chr2) depends on molecular chaperone DnaK to facilitate binding of the initiator (RctB) to the replication origin. The binding occurs at two kinds of site, 12-mers and 39-mers, which promote and inhibit replication, respectively. Here we show that DnaK employs different mechanisms to enhance the two kinds of binding. We found that mutations in rctB that reduce DnaK binding also reduce 12-mer binding and initiation. The initiation defect is suppressed by second-site mutations that increase 12-mer binding only marginally. Instead, they reduce replication inhibitory mechanisms: RctB dimerization and 39-mer binding. One suppressing change was in a dimerization domain which is folded similarly to the initiator of an iteron plasmid-the presumed progenitor of Chr2. In plasmids, DnaK promotes initiation by reducing dimerization. A different mutation was in the 39-mer binding domain of RctB and inactivated it, indicating an alternative suppression mechanism. Paradoxically, although DnaK increases 39-mer binding, the increase was also achieved by inactivating the DnaK binding site of RctB. This result suggests that the site inhibits the 39-mer binding domain (via autoinhibition) when prevented from binding DnaK. Taken together, our results reveal an important feature of the transition from plasmid to chromosome: the Chr2 initiator retains the plasmid-like dimerization domain and its control by chaperones but uses the chaperones in an unprecedented way to control the inhibitory 39-mer binding.IMPORTANCE The capacity of proteins to undergo remodeling provides opportunities to control their function. However, remodeling remains a poorly understood aspect of the structure-function paradigm due to its dynamic nature. Here we have studied remodeling of the initiator of replication of Vibrio cholerae Chr2 by the molecular chaperone, DnaK. We show that DnaK binds to a site on the Chr2 initiator (RctB) that promotes initiation by reducing the initiator's propensity to dimerize. Dimerization of the initiator of the putative plasmid progenitor of Chr2 is also reduced by DnaK, which promotes initiation. Paradoxically, the DnaK binding also promotes replication inhibition by reducing an autoinhibitory activity of RctB. In the plasmid-to-chromosome transition, it appears that the initiator has acquired an autoinhibitory activity and along with it a new chaperone activity that apparently helps to control replication inhibition independently of replication promotion.


Sujet(s)
Protéines bactériennes/métabolisme , Chromosomes de bactérie/métabolisme , Helicase/métabolisme , Réplication de l'ADN , ADN bactérien/métabolisme , Chaperons moléculaires/métabolisme , Transactivateurs/métabolisme , Vibrio cholerae/enzymologie , Vibrio cholerae/génétique , Liaison aux protéines , Multimérisation de protéines , Origine de réplication , Vibrio cholerae/croissance et développement
16.
Microbiol Mol Biol Rev ; 81(1)2017 03.
Article de Anglais | MEDLINE | ID: mdl-27903655

RÉSUMÉ

Bacterial chromosomes initiate replication at a fixed time in the cell cycle, whereas there is generally no particular time for plasmid replication initiation or chromosomal replication initiation from integrated plasmids. In bacteria with divided genomes, the replication system of one of the chromosomes typically resembles that of bacteria with undivided genomes, whereas the remaining chromosomes have plasmid-like replication systems. For example, in Vibrio cholerae, a bacterium with two chromosomes (chromosome 1 [Chr1] and Chr2), the Chr1 system resembles that of the Escherichia coli chromosome, and the Chr2 system resembles that of iteron-based plasmids. However, Chr2 still initiates replication at a fixed time in the cell cycle and thus offers an opportunity to understand the molecular basis for the difference between random and cell cycle-regulated modes of replication. Here we review studies of replication control in Chr2 and compare it to those of plasmids and chromosomes. We argue that although the Chr2 control mechanisms in many ways are reminiscent of those of plasmids, they also appear to combine more regulatory features than are found on a typical plasmid, including some that are more typical of chromosomes. One of the regulatory mechanisms is especially novel, the coordinated timing of replication initiation of Chr1 and Chr2, providing the first example of communication between chromosomes for replication initiation.


Sujet(s)
Chromosomes de bactérie/génétique , Réplication de l'ADN/génétique , Escherichia coli/génétique , Vibrio cholerae/génétique , Cycle cellulaire/génétique , ADN bactérien/génétique , Dosage génique/génétique , Plasmides/génétique
17.
PLoS One ; 11(12): e0166722, 2016.
Article de Anglais | MEDLINE | ID: mdl-27930658

RÉSUMÉ

The Escherichia coli origin of replication, oriC, comprises mostly binding sites of two proteins: DnaA, a positive regulator, and SeqA, a negative regulator. SeqA, although not essential, is required for timely initiation, and during rapid growth, synchronous initiation from multiple origins. Unlike DnaA, details of SeqA binding to oriC are limited. Here we have determined that SeqA binds to all its sites tested (9/11) and with variable efficiency. Titration of DnaA alters SeqA binding to two sites, both of which have overlapping DnaA sites. The altered SeqA binding, however, does not affect initiation synchrony. Synchrony is also unaffected when individual SeqA sites are mutated. An apparent exception was one mutant where the mutation also changed an overlapping DnaA site. In this mutant, the observed asynchrony could be from altered DnaA binding, as selectively mutating this SeqA site did not cause asynchrony. These results reveal robust initiation synchrony against alterations of individual SeqA binding sites. The redundancy apparently ensures SeqA function in controlling replication in E. coli.


Sujet(s)
Protéines de la membrane externe bactérienne/métabolisme , Réplication de l'ADN , Protéines de liaison à l'ADN/métabolisme , Protéines Escherichia coli/métabolisme , Escherichia coli/métabolisme , Protéines de la membrane externe bactérienne/génétique , Sites de fixation , Technique de Southern , Réplication de l'ADN/génétique , Protéines de liaison à l'ADN/génétique , Escherichia coli/génétique , Protéines Escherichia coli/génétique , Cytométrie en flux , Réaction de polymérisation en chaîne , Origine de réplication/génétique , Origine de réplication/physiologie
18.
Front Mol Biosci ; 3: 62, 2016.
Article de Anglais | MEDLINE | ID: mdl-27747216

RÉSUMÉ

The local separation of duplex DNA strands (strand opening) is necessary for initiating basic transactions on DNA such as transcription, replication, and homologous recombination. Strand opening is commonly a stage at which these processes are regulated. Many different mechanisms are used to open the DNA duplex, the details of which are of great current interest. In this review, we focus on a few well-studied cases of DNA replication origin opening in bacteria. In particular, we discuss the opening of origins that support the theta (θ) mode of replication, which is used by all chromosomal origins and many extra-chromosomal elements such as plasmids and phages. Although the details of opening can vary among different origins, a common theme is binding of the initiator to multiple sites at the origin, causing stress that opens an adjacent and intrinsically unstable A+T rich region. The initiator stabilizes the opening by capturing one of the open strands. How the initiator binding energy is harnessed for strand opening remains to be understood.

19.
Physiol Plant ; 154(4): 543-59, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-25302555

RÉSUMÉ

The predicted increase in the frequency and magnitude of extreme heat spikes under future climate can reduce rice yields significantly. Rice sensitivity to high temperatures during the reproductive stage is well documented while the same during the vegetative stage is more speculative. Hence, to identify and characterize novel heat-tolerant donors for both the vegetative and reproductive stages, 71 rice accessions, including approximately 75% New Rice for Africa (NERICAs), were phenotyped across field experiments during summer seasons in Delhi, India, and in a controlled environment study at International Rice Research Institute, Philippines. NERICA-L-44 (NL-44) recorded high seedling survival (52%) and superior growth and greater reproductive success exposed to 42.2°C (sd ± 2.3) under field conditions. NL-44 and the heat-tolerant check N22 consistently displayed lower membrane damage and higher antioxidant enzymes activity across leaves and spikelets. NL-44 recorded 50-60% spikelet fertility, while N22 recorded 67-79% under controlled environment temperature of 38°C (sd±1.17), although both had about 87% fertility under extremely hot field conditions. N22 and NL-44, exposed to heat stress (38°C), had similar pollen germination percent and number of pollen tubes reaching the ovary. NL-44 maintained low hydrogen peroxide production and non-photochemical quenching (NPQ) with high photosynthesis while N22 avoided photosystem II damage through high NPQ under high-temperature stress. NL-44 with its reproductive stage resilience to extreme heat stress, better antioxidant scavenging ability in both vegetative tissue and spikelets and superior yield and grain quality is identified as a novel donor for increasing heat tolerance at both the vegetative and reproductive stages in rice.


Sujet(s)
Adaptation physiologique , Température élevée , Oryza/physiologie , Protéines végétales/physiologie , Antioxydants/métabolisme , Chlorophylle/métabolisme , Fleurs/croissance et développement , Stress oxydatif , Reproduction
20.
Nucleic Acids Res ; 42(16): 10538-49, 2014.
Article de Anglais | MEDLINE | ID: mdl-25159619

RÉSUMÉ

RctB, the initiator of replication of Vibrio cholerae chromosome 2 (chr2), binds to the origin of replication to specific 12-mer sites both as a monomer and a dimer. Binding to 12-mers is essential for initiation. The monomers also bind to a second kind of site, 39-mers, which inhibits initiation. Mutations in rctB that reduce dimer binding increase monomer binding to 12-mers but decrease monomer binding to 39-mers. The mechanism of this paradoxical binding behavior has been unclear. Using deletion and alanine substitution mutants of RctB, we have now localized to a 71 amino acid region residues important for binding to the two kinds of DNA sites and for RctB dimerization. We find that the dimerization domain overlaps with both the DNA binding domains, explaining how changes in the dimerization domain can alter both kinds of DNA binding. Moreover, dimerization-defective mutants could be initiation-defective without apparent DNA binding defect. These results suggest that dimerization might be important for initiation beyond its role in controlling DNA binding. The finding that determinants of crucial initiator functions reside in a small region makes the region an attractive target for anti-V. cholerae drugs.


Sujet(s)
Protéines bactériennes/composition chimique , Protéines bactériennes/métabolisme , Chromosomes de bactérie , Réplication de l'ADN , Protéines de liaison à l'ADN/composition chimique , Protéines de liaison à l'ADN/métabolisme , Vibrio cholerae/génétique , ADN/biosynthèse , ADN/métabolisme , Liaison aux protéines , Multimérisation de protéines , Structure tertiaire des protéines
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE